Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Suter Widmer, Isabelle ^a   Christ Crain, Mirjam ^a   Zimmerli, Werner ^b   Albrich, Werner ^c   Mueller, Beat ^c   Schuetz, Philipp ^c,d   Schild, Ursula ^e   Regez, Katharina ^e   Bossart, Rita ^e   Thomann, Robert ^e   Falconnier, Claudine ^e   Wolbers, Marcel ^e   Meyer Neidert, Stefanie ^e   Fricker, Thomas ^e   Blum, Claudine ^e   Schoenenberger, Ronald ^e   Henzen, Christoph ^e   Bregenzer, Thomas ^e   Hoess, Claus ^e   Krause, Martin ^e   Bucher, Heiner C ^e   Mueller, Fabian ^e   Haeuptle, Jeannine ^e   Zarbosky, Roya ^e   Fiumefreddo, Rico ^e   Wieland, Melanie ^e   Nusbaumer, Charly ^e   Christ, Andres ^e   Bingisser, Roland ^e   Schneider, Kristian ^e   Vincenzi, Christine ^e   Kleinknecht, Michael ^e   Walz, Brigitte ^e   Briner, Verena ^e   Conen, Dieter ^e   Huber, Andreas ^e   Staehelin, Jody ^e   Aarau, Chantal Bruehlhardt ^e   Luginbuehl, Ruth ^e   Muehlemann, Agne ^e   lambinon, Ineke ^e   Zueger, Max ^e   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KANTONSSPITAL LIESTAL   (Switzerland)

^c Medical University Clinic   (Switzerland)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BODY TEMPERATURE; BREATHING RATE; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CLINICAL EXAMINATION; COMMUNITY ACQUIRED PNEUMONIA; DIABETES MELLITUS; DISEASE SEVERITY; EMERGENCY CARE; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEART FAILURE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SWITZERLAND; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CONFUSION; FEMALE; HUMANS; INSURANCE, HEALTH; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; PROPORTIONAL HAZARDS MODELS; RESPIRATORY RATE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWITZERLAND;

EID: 84861150745     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-21     Document Type: Article

References (32)

1. Mizgerd JP. Lung infection-a public health priority. PLoS Med 2006, 3(2):e76. 10.1371/journal.pmed.0030076, 1326257, 16401173.
2. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72.
3. Bundesamt für Statistik S 2008, editor, Ref Type: Online Source, [http://www.bfs.admin.ch/bfs/portal/de/index ][http://www.bfs.admin.ch/bfs/portal/de/index.html].
4. Bauer M, Fitzgerald L, Haesler E, Manfrin M. Hospital discharge planning for frail older people and their family. Are we delivering best practice? A review of the evidence. J Clin Nurs 2009, 18:2539-2546. 10.1111/j.1365-2702.2008.02685.x, 19374695.
5. Garau J, Baquero F, Perez-Trallero E, et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008, 14(4):322-329. 10.1111/j.1469-0691.2007.01915.x, 18190569.
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336(4):243-250. 10.1056/NEJM199701233360402, 8995086.
7. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58(5):377-382. 10.1136/thorax.58.5.377, 1746657, 12728155.
8. Kaysar M, Augustine T, Jim L, Benjamin C. Predictors of length of stay between the young and aged in hospitalized community-acquired pneumonia patients. Geriatr Gerontol Int 2008, 8(4):227-233. 10.1111/j.1447-0594.2008.00480.x, 19149833.
9. Masotti L, Ceccarelli E, Cappelli R, Barabesi L, Guerrini M, Forconi S. Length of hospitalization in elderly patients with community-acquired pneumonia. Aging (Milano) 2000, 12(1):35-41.
10. Menendez R, Ferrando D, Valles JM, Martinez E, Perpina M. Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J 2001, 18(1):151-156. 10.1183/09031936.01.00090001, 11510787.
11. Menendez R, Cremades MJ, Martinez-Moragon E, Soler JJ, Reyes S, Perpina M. Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J 2003, 22(4):643-648. 10.1183/09031936.03.00026103, 14582918.
12. Schuetz P, Christ-Crain M, Wolbers M, et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 2007, 7:102. 10.1186/1472-6963-7-102, 1947969, 17615073.
13. Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 1995, 51(4):1469-1482. 10.2307/2533277, 8589234.
14. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302(10):1059-1066. 10.1001/jama.2009.1297, 19738090.
15. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363(9409):600-607. 10.1016/S0140-6736(04)15591-8, 14987884.
16. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174(1):84-93. 10.1164/rccm.200512-1922OC, 16603606.
17. Aliyu ZY, Aliyu MH, McCormick K. Determinants for hospitalization in "low-risk" community acquired pneumonia. BMC Infect Dis 2003, 3:11. 10.1186/1471-2334-3-11, 165606, 12809564.
18. Coley CM, Li YH, Medsger AR, et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med 1996, 156(14):1565-1571. 10.1001/archinte.1996.00440130115012, 8687265.
19. Labarere J, Stone RA, Scott OD, et al. Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial. J Gen Intern Med 2006, 21(7):745-752. 10.1111/j.1525-1497.2006.00510.x, 1924717, 16808776.
20. McGregor MJ, Fitzgerald JM, Reid RJ, et al. Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. Can Respir J 2005, 12(7):365-370.
21. Arnold FW, LaJoie AS, Brock GN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009, 169(16):1515-1524. 10.1001/archinternmed.2009.265, 19752410.
22. Athanassa Z, Makris G, Dimopoulos G, Falagas ME. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs 2008, 68(17):2469-2481. 10.2165/0003495-200868170-00005, 19016574.
23. Bewick T, Cooper VJ, Lim WS. Does early review by a respiratory physician lead to a shorter length of stay for patients with non-severe community-acquired pneumonia?. Thorax 2009, 64(8):709-712. 10.1136/thx.2008.109983, 19386582.
24. Fung HB, Monteagudo-Chu MO. Community-acquired pneumonia in the elderly. Am J Geriatr Pharmacother 2010, 8(1):47-62. 10.1016/j.amjopharm.2010.01.003, 20226392.
25. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999, 159(21):2562-2572. 10.1001/archinte.159.21.2562, 10573046.
26. Martinez R, Reyes S, Lorenzo MJ, Menendez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 2009, 30(2):172-178. 10.1055/s-0029-1202936, 19296417.
27. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009, 169(16):1525-1531. 10.1001/archinternmed.2009.259, 19752411.
28. Pines JM, Isserman JA, Hinfey PB. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 2009, 37(3):335-340. 10.1016/j.jemermed.2009.06.127, 19717266.
29. Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999, 159(21):2576-2580. 10.1001/archinte.159.21.2576, 10573047.
30. Capelastegui A, Espana PP, Quintana JM, et al. Declining length of hospital stay for pneumonia and postdischarge outcomes. Am J Med 2008, 121(10):845-852. 10.1016/j.amjmed.2008.05.010, 18823851.
31. Southern WN, Berger MA, Bellin EY, Hailpern SM, Arnsten JH. Hospitalist care and length of stay in patients requiring complex discharge planning and close clinical monitoring. Arch Intern Med 2007, 167(17):1869-1874. 10.1001/archinte.167.17.1869, 2838181, 17893308.
32. Sala E, Alegre L, Carrera M, et al. Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD. Eur Respir J 2001, 17(6):1138-1142. 10.1183/09031936.01.00068201, 11491156.